These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10022727)

  • 21. Is resolution of vesicoureteric reflux by conservative management predictable in patients with myelodysplasia?
    Ulman I; Avanoğlu A; Erikçi V; Gökdemir A
    Eur Urol; 1998 Sep; 34(3):226-9. PubMed ID: 9732198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of myelomeningocele.
    Kaplan WE
    Urol Clin North Am; 1985 Feb; 12(1):93-101. PubMed ID: 3883627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
    Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
    J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An objective score to predict upper tract deterioration in myelodysplasia.
    Galloway NT; Mekras JA; Helms M; Webster GD
    J Urol; 1991 Mar; 145(3):535-7. PubMed ID: 1997704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urodynamic predictors of upper tract deterioration in children with myelodysplasia.
    Shoukry MS; El Salmy S; Aly GA; Mokhless I
    Scand J Urol Nephrol; 1998 Apr; 32(2):94-7. PubMed ID: 9606778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal scarring and vesicoureteral reflux in children with myelodysplasia.
    Cohen RA; Rushton HG; Belman AB; Kass EJ; Majd M; Shaer C
    J Urol; 1990 Aug; 144(2 Pt 2):541-4; discussion 545. PubMed ID: 2165187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy.
    Edelstein RA; Bauer SB; Kelly MD; Darbey MM; Peters CA; Atala A; Mandell J; Colodny AH; Retik AB
    J Urol; 1995 Oct; 154(4):1500-4. PubMed ID: 7658577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiographic abnormalities, bladder interventions, and bladder surgery in the first decade of life in children with spina bifida.
    Rensing AJ; Szymanski KM; Misseri R; Roth JD; King S; Chan K; Whittam BM; Kaefer M; Rink RC; Cain MP
    Pediatr Nephrol; 2019 Jul; 34(7):1277-1282. PubMed ID: 30826869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ileocecal bladder augmentation in myelodysplasia.
    Mayo ME; Chapman WH
    J Urol; 1988 Apr; 139(4):786-9. PubMed ID: 3352043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clean intermittent catheterization in the management of the neurogenic bladder in children.
    Cass AS; Luxenberg M; Gleich P; Johnson CF; Hagen S
    J Urol; 1984 Sep; 132(3):526-8. PubMed ID: 6471189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicostomy revisited: the best treatment for the hostile bladder in myelodysplastic children?
    Morrisroe SN; O'Connor RC; Nanigian DK; Kurzrock EA; Stone AR
    BJU Int; 2005 Aug; 96(3):397-400. PubMed ID: 16042737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clean intermittent catheterization in the management of spina bifida: a review of 113 cases].
    Yamamoto M; Yasukawa M; Yoshii M; Takahashi S; Natsume O; Momose H; Suemori T; Yamada K; Shiomi T
    Hinyokika Kiyo; 1991 Feb; 37(2):117-21. PubMed ID: 2048490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does treatment with clean intermittent catheterization in boys with posterior urethral valves affect bladder and renal function?
    Holmdahl G; Sillen U; Hellström AL; Sixt R; Sölsnes E
    J Urol; 2003 Oct; 170(4 Pt 2):1681-5; discussion 1685. PubMed ID: 14501691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urethral opening pressure in patients with myelodysplasia.
    Yamamoto M; Natsume O; Yamada K; Momose H; Shiomi T; Hirata N; Hirayama A; Tanaka Y; Hirao Y; Okajima E
    Spinal Cord; 1996 Aug; 34(8):493-7. PubMed ID: 8856858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management of vesicoureteral reflux in the setting of posterior urethral valve with emphasis on bladder function and renal outcome: a single center cohort study.
    Tourchi A; Kajbafzadeh AM; Aryan Z; Ebadi M
    Urology; 2014 Jan; 83(1):199-205. PubMed ID: 24149109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for febrile urinary tract infection in children with myelodysplasia treated by clean intermittent catheterization.
    Seki N; Masuda K; Kinukawa N; Senoh K; Naito S
    Int J Urol; 2004 Nov; 11(11):973-7. PubMed ID: 15509200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study.
    McGuire EJ; Woodside JR; Borden TA
    J Urol; 1983 Apr; 129(4):823-6. PubMed ID: 6842712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia.
    Tanaka H; Matsuda M; Moriya K; Mitsui T; Kitta T; Nonomura K
    J Urol; 2008 Jul; 180(1):312-6; discussion 316. PubMed ID: 18499168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of vesicoureteral reflux in children with neurogenic bladders.
    Kass EJ; Koff SA
    Z Kinderchir; 1981 Dec; 34(4):379-83. PubMed ID: 7331545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New hydronephrosis and/or vesicoureteral reflux after bladder outlet surgery without augmentation in 75 children with neurogenic bladder.
    Snodgrass W; Villanueva C; Gargollo P; Jacobs M
    J Pediatr Urol; 2014 Oct; 10(5):906-10. PubMed ID: 24680474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.